Global Monoclonal Antibody Development and Production Service Market Growth (Status and Outlook) 2025-2031

The global Monoclonal Antibody Development and Production Service market size is predicted to grow from US$ 810 million in 2025 to US$ 1184 million in 2031; it is expected to grow at a CAGR of 6.5% from 2025 to 2031.

Monoclonal Antibody Development and Production Service refers to providing service for the development and production of specific monoclonal antibodies (mAbs). Monoclonal antibodies are derived from a single B cell clone and therefore have high specificity and consistency. The production process usually includes antigen design and preparation, immunization of mice or other hosts, B cell fusion, hybridoma screening, clone amplification, antibody purification, and other steps, ultimately obtaining high-purity, high affinity monoclonal antibodies.

United States market for Monoclonal Antibody Development and Production Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Monoclonal Antibody Development and Production Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Monoclonal Antibody Development and Production Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Monoclonal Antibody Development and Production Service players cover ThermoFisher, Abcam, BICO, Rockland, ProSci, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Monoclonal Antibody Development and Production Service Industry Forecast” looks at past sales and reviews total world Monoclonal Antibody Development and Production Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Monoclonal Antibody Development and Production Service sales for 2025 through 2031. With Monoclonal Antibody Development and Production Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monoclonal Antibody Development and Production Service industry.

This Insight Report provides a comprehensive analysis of the global Monoclonal Antibody Development and Production Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Monoclonal Antibody Development and Production Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Monoclonal Antibody Development and Production Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monoclonal Antibody Development and Production Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monoclonal Antibody Development and Production Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Monoclonal Antibody Development and Production Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
Human Monoclonal Antibodies
Mouse Monoclonal Antibodies
Others

Segmentation by Application:
Medical
Pharmaceutical
Scientific Research

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
ThermoFisher
Abcam
BICO
Rockland
ProSci
Biocompare
Bio-Rad
Evitria AG
Capra Science
Innovagen
Life Science Group
Randox
Davids Biotechnologie
Abgent
InVivo BioTech Services
BioGenes
Helmholtz Zentrum München
Kaneka Eurogentec
Beijing Abace Biology
Beijing Sino Biological
Nanjing GenScript Biotechnology
Shanghai Sangon Biotech
Nanjing Zoonbio Biotechnology
Suzhou Synbio Technologies

Please note: The report will take approximately 2 business days to prepare and deliver.